Does CANDESARTAN Cause Onychomadesis? 480 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 480 reports of Onychomadesis have been filed in association with CANDESARTAN. This represents 5.3% of all adverse event reports for CANDESARTAN.
480
Reports of Onychomadesis with CANDESARTAN
5.3%
of all CANDESARTAN reports
480
Deaths
416
Hospitalizations
How Dangerous Is Onychomadesis From CANDESARTAN?
Of the 480 reports, 480 (100.0%) resulted in death, 416 (86.7%) required hospitalization, and 418 (87.1%) were considered life-threatening.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 480 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
SECUKINUMAB (678)
LEFLUNOMIDE (667)
GOLIMUMAB (660)
HYDROXYCHLOROQUINE (660)
Which CANDESARTAN Alternatives Have Lower Onychomadesis Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL